Clinical Trials Sponsored by Medbuy Corporation

Total 6540 results

Unity Health Toronto
Medbuy Pharmacy

Unknown

Use of a Support Bra to Reduce Pain and Improve Surgical Healing in Women Undergoing Sternotomy for Cardiac Surgery

Quality of Life | Pain | Disruption or Dehiscence of Closure of Sternum or Sternotomy

Canada
Lawson Health Research Institute
London Health Sciences Centre; University of Waterloo; Medbuy Corporation

Completed

A Trial to Assess the Influence of a Pictorial Medication Calendar on Medication Taking Behaviour

Cancer | Chemotherapy | Medication Adherence

Canada
Medhub Ltd.

Unknown

Post Marketing Clinical Trial to Demonstrate the Performance of the MedHub AutocathFFR Device.

Coronary Artery Disease
Medhub Ltd.

Completed

Pivotal, Single-arm Clinical Trial to Assess the Efficacy and Safety of the MedHub AutocathFFR Software Device (AutocathFFR)

Stable Angina | Unstable Angina | NSTEMI

Israel
MedDay Pharmaceuticals SA

Completed

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Charcot-Marie-Tooth Disease | Peripheral Neuropathy | Chronic Inflammatory Demyelinating Polyneuropathy | Charcot-Marie-Tooth Disease Type 1A | Charcot-Marie-Tooth Disease, Type 1B | Anti-MAG Neuropathy

France
MedDay Pharmaceuticals SA

Unknown

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis (MS-ON)

Multiple Sclerosis

United Kingdom, France
MedDay Pharmaceuticals SA

Unknown

Effect of MD1003 in Spinal Progressive Multiple Sclerosis (MS-SPI)

Multiple Sclerosis

France
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
MedDay Pharmaceuticals SA

Terminated

Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) (SPI2)

Multiple Sclerosis

United States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
MedDay Pharmaceuticals SA

Completed

MD1003-AMN MD1003 in Adrenomyeloneuropathy

Adrenoleukodystrophy | Adrenomyeloneuropathy | AMN

France, Germany, Spain
Medway NHS Foundation Trust

Withdrawn

A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding

Overactive Bladder | Urinary Incontinence | Voiding Dysfunction
MedDay Pharmaceuticals SA

Completed

Effect of MD1003 in Amyotrophic Lateral Sclerosis (MD1003-ALS)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | ALS

France
MedCu Technologies Ltd.

Terminated

Efficacy of Wound Dressings With Copper Oxide

Diabetic Foot Ulcer | Pressure Ulcer

Israel
MedCu Technologies Ltd.

Completed

Comparison of Wound Healing Between MedCu Dressings With Copper Oxide and Negative Pressure Wound Therapy Treatment

Wounds and Injuries | Diabetic Foot Ulcer | Negative Pressure Therapy

Israel
Medway NHS Foundation Trust

Recruiting

Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes (ULOOP)

Hypoxic-Ischemic Encephalopathy | Admission to Neonatal Unit | Stillbirth | Small for Gestational Age at Delivery

United Kingdom
Medway Primary Care Trust

Completed

Observing the Perioperative Effects of Prehabilitation in Colorectal Cancer Patients

Colon Cancer

United Kingdom
Medway NHS Foundation Trust

Completed

Vibration Training and Pelvic Floor Muscle Strength in Females With Stress Urinary Incontinence

Urinary Stress Incontinence

United Kingdom
Medway NHS Foundation Trust

Completed

A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder

Urogynaecology

United Kingdom
Medway NHS Foundation Trust

Unknown

The Effect of Catheter Valve Vs. Standard Catheter Removal in Outpatients

Urinary Retention

United Kingdom
Medway NHS Foundation Trust

Completed

Cystoscopy and Cystodistension; Therapeutic and Aetiological Aspect in Overactive Bladder

Urinary Incontinence, Urge

United Kingdom
Medway Primary Care Trust

Completed

Surgical Consent During the COVID-19 Pandemic

Consent

United Kingdom
Medway NHS Foundation Trust

Completed

A Long Term Follow up of Anterior Meshes for Recurrent Prolapse

Pelvic Organ Prolapse | Genital Diseases, Female

United Kingdom
Medway NHS Foundation Trust

Completed

Tension Free Vaginal Tape (TVT) Versus the Miniarc Sling

Urodynamic Stress Incontinence

United Kingdom
Medway NHS Foundation Trust

Unknown

Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding

Overactive Bladder Syndrome | Voiding Dysfunction

United Kingdom
MedCu Technologies Ltd.

Completed

Safety and Efficacy Study of MedCu Wound Dressings

Wounds and Injuries | Diabetes Complications

Israel
Medy-Tox

Completed

Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat

Submental Fat

Korea, Republic of
Medy-Tox

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines

Lateral Canthal Lines

Australia
Medy-Tox

Completed

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines

Glabellar Frown Lines

Australia
Medy-Tox

Completed

A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat

Submental Fat

Korea, Republic of
Medy-Tox

Completed

Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity

Muscle Spasticity
Medy-Tox

Completed

Efficacy and Safety Study of Neuramis in Correction of Nasolabial Fold

Nasolabial Fold

Korea, Republic of
Medy-Tox

Completed

Pharmacodynamic and Safety of MEDITOXIN® in Healthy Male Volunteers

Healthy

Korea, Republic of
Medy-Tox

Completed

The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

MEDITOXIN® in Treatment of Crow's Feet Line

Crow's Feet Lines

Korea, Republic of
Medway NHS Foundation Trust
Johnson & Johnson

Unknown

Feasibility of a Trial of Laparoscopic Hysterectomy Versus Laparoscopic Sub-Total Hysterectomy (LaHoST)

Benign Disease of the Uterus

United Kingdom
MedDay Pharmaceuticals SA
Eurofins Optimed

Terminated

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

Healthy Volunteers | Impaired Renal Function

France, Hungary
MedDay Pharmaceuticals SA
Quotient Sciences

Completed

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
MedDay Pharmaceuticals SA
Eurofins Optimed

Terminated

HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects

Healthy Volunteers | Hepatic Impairment of Moderate Child Pugh Category

France, Hungary
Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System (ACCESS PTS)

Deep Vein Thrombosis | Post-thrombotic Syndrome

United States
Guidant Corporation
Boston Scientific Corporation

Completed

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device (SEPTAL-CRT)

Ventricular Fibrillation | Ventricular Tachycardia | Systolic Heart Failure

France, Spain
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland

Clinical Trials Sponsored by Medbuy Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations